ELIAS Animal Health Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $430K

  • Investors
  • 5

ELIAS Animal Health General Information

Description

Operator of a medical biotechnology company intended to provide cancer treatment for pets. The company helps harness the power of the dog's immune system to eliminate cancer by utilizing adoptive cell therapy to deliver an army of activated T-cells that kill cancer cells, enabling veterinarians and pet owners to have access to a new approach to cancer treatment.

Contact Information

Formerly Known As
TVAX Animal Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10049 Lakeview Avenue
  • Lenexa, KS 66219
  • United States
Primary Industry
Other Services (B2C Non-Financial)
Vertical(s)
Corporate Office
  • 10049 Lakeview Avenue
  • Lenexa, KS 66219
  • United States

ELIAS Animal Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ELIAS Animal Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 29-Dec-2025 $430K Completed Generating Revenue
7. Later Stage VC (Series A) 10-Apr-2024 Completed Clinical Trials - General
6. Later Stage VC 21-Sep-2022 Completed Clinical Trials - General
5. Later Stage VC 13-May-2020 Completed Clinical Trials - General
4. Later Stage VC 22-Jan-2020 Cancelled Clinical Trials - General
3. Seed Round 10-May-2017 Completed Clinical Trials - General
2. Seed Round 26-Mar-2015 $2M $12M Completed Clinical Trials - General
1. Seed Round $10M $10M Completed Startup
To view ELIAS Animal Health’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ELIAS Animal Health Patents

ELIAS Animal Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025259866-A2 Combination of chemotherapy, cancer cell vaccine and adoptive cell therapy Pending 14-Jun-2024
WO-2025259866-A3 Combination of chemotherapy, cancer cell vaccine and adoptive cell therapy Pending 14-Jun-2024
EP-4727562-A1 Use of cd200ar-l for enhancing adoptive t-cell therapy Pending 16-Jun-2023
WO-2024259195-A1 Use of cd200ar-l for enhancing adoptive t-cell therapy Inactive 16-Jun-2023 A61K40/11

ELIAS Animal Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ELIAS Animal Health Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
eGrowth Ventures Not-For-Profit Venture Capital Minority
Kansas Bioscience Authority Government Minority
Mid America Angels Angel Group Minority
Women's Capital Connection Angel Group Minority
Angel (individual) Minority
To view ELIAS Animal Health’s complete investors history, request access »

ELIAS Animal Health FAQs

  • When was ELIAS Animal Health founded?

    ELIAS Animal Health was founded in 2014.

  • Where is ELIAS Animal Health headquartered?

    ELIAS Animal Health is headquartered in Lenexa, KS.

  • What is the size of ELIAS Animal Health?

    ELIAS Animal Health has 8 total employees.

  • What industry is ELIAS Animal Health in?

    ELIAS Animal Health’s primary industry is Other Services (B2C Non-Financial).

  • Is ELIAS Animal Health a private or public company?

    ELIAS Animal Health is a Private company.

  • What is ELIAS Animal Health’s current revenue?

    The current revenue for ELIAS Animal Health is .

  • How much funding has ELIAS Animal Health raised over time?

    ELIAS Animal Health has raised $31.1M.

  • Who are ELIAS Animal Health’s investors?

    eGrowth Ventures, Kansas Bioscience Authority, Mid America Angels, Women's Capital Connection, and have invested in ELIAS Animal Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process